Neonc Technologies Holdings, Inc. cash flow statement
In fiscal 2025, Neonc Technologies Holdings, Inc.'s operations generated −$20.4m of cash; it spent $500,000 on capital projects, leaving free cash flow of −$20.9m.
Cash flow statement
Compare with peers
- Lyell Immunopharma, Inc. cash flow
- AIM Immunotech Inc. cash flow
- Ibio, Inc. cash flow
- Lisata Therapeutics, Inc. cash flow
- Celldex Therapeutics, Inc. cash flow
Head to head: LYEL vs NTHIAIM vs NTHIIBIO vs NTHI
More: Biotechnology stocks compared, Health Care sector, rankings of US companies